KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) EPS (Basic) (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed EPS (Basic) for 11 consecutive years, with -$0.76 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 300.0% to -$0.76 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.96 through Dec 2025, down 39.01% year-over-year, with the annual reading at -$1.97 for FY2025, 39.72% down from the prior year.
  • EPS (Basic) hit -$0.76 in Q4 2025 for Fulgent Genetics, down from -$0.21 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $6.96 in Q1 2021 to a low of -$4.3 in Q4 2023.
  • Historically, EPS (Basic) has averaged $0.65 across 5 years, with a median of -$0.33 in 2024.
  • Biggest five-year swings in EPS (Basic): soared 7833.33% in 2021 and later tumbled 833.33% in 2023.
  • Year by year, EPS (Basic) stood at $3.48 in 2021, then tumbled by 122.99% to -$0.8 in 2022, then plummeted by 437.5% to -$4.3 in 2023, then skyrocketed by 95.58% to -$0.19 in 2024, then plummeted by 300.0% to -$0.76 in 2025.
  • Business Quant data shows EPS (Basic) for FLGT at -$0.76 in Q4 2025, -$0.21 in Q3 2025, and -$0.62 in Q2 2025.